AJKD Blog

Rituximab effectively limits the number of relapses in childhood idiopathic nephrotic syndromes (INS) and reduces exposure to corticosteroids and other immunosuppressants. However, few data are available on the risk of relapse after an initial dose of rituximab or the benefit of a maintenance therapy in adults with INS. Laslandes et al followed 134 French adults for a median of 36 months to test its effectiveness. AJKDBlog’s Interviews Editor, Timothy Yau (@Maximal_Change), recently sat down [...]

Dr. Justin Oveyssi is an Assistant Clinical Professor of Medicine in Transplant Nephrology at UCSF. His clinical and academic work focuses on post–kidney transplant care, including immune-mediated complications and long-term outcomes in transplant recipients. He is passionate about improving care coordination and long-term follow-up for living kidney donors and transplant patients. Living kidney donors are often described as heroes. They are individuals who voluntarily accept surgical and [...]

Editor’s Note: We asked authors of Original Investigations to provide short plain-language summaries that would briefly summarize what inspired their study, the basic approach taken, what was learned, and why it matters. We hope our readers will find this valuable in helping them keep up with the latest research in the field of nephrology. Highlights from the July 2026 issue: Prevalence of CKD Among Adults in Africa: A Systematic Review and Meta-Analysis by Cindy George et al. [OPEN [...]

So many eminently qualified applicants responded to our recent call for applications to the AJKD Editorial Internship Program, the editors were both impressed, and saddened that they could only pick 5. Please join us in welcoming our ninth class, the 2026-27 AJKD Editorial Interns: Natalie Hobeika, Patrick Hofmann, Michael Reaume, Amara Sarwal, and Emily K. Yeung.   Natalie Hobeika Natalie Hobeika is a current nephrology fellow at Northwestern University in Chicago, Illinois. Born and [...]

Atrial fibrillation is common among patients with kidney failure treated with hemodialysis. A recent study published in AJKD by Winkelmayer et al examined the efficacy and safety of apixaban for atrial fibrillation in patients on dialysis. AJKDBlog’s Interviews Editor Timothy Yau chatted with author Wolfgang C. Winkelmayer about the clinical conundrum of both increased stroke and increased bleeding risk in patients on dialysis and how this affects the decision to anticoagulate. They review [...]